Patents by Inventor Whitney L. Gladney

Whitney L. Gladney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds useful for inhibiting metastasis from cancer and methods using same
    Patent number: 10414771
    Abstract: The present invention includes compositions that are useful in preventing or treating metastasis in a subject diagnosed with cancer. The present invention also includes methods of preventing or treating metastasis in a subject diagnosed with cancer, wherein the method comprises administering to the subject in need thereof an effective amount of a pharmaceutical formulation comprising at least one pharmaceutically acceptable carrier and at least one CX3CR1 or fractalkine antagonist.
    Type: Grant
    Filed: November 22, 2017
    Date of Patent: September 17, 2019
    Assignees: Drexel University, Alliance Discovery, Inc.
    Inventors: Alessandro Fatatis, Joseph M. Salvino, Olimpia Meucci, Whitney L. Gladney
  • Compounds Useful for Inhibiting Metastasis from Cancer and Methods Using Same
    Publication number: 20180099972
    Abstract: The present invention includes compositions that are useful in preventing or treating metastasis in a subject diagnosed with cancer. The present invention also includes methods of preventing or treating metastasis in a subject diagnosed with cancer, wherein the method comprises administering to the subject in need thereof an effective amount of a pharmaceutical formulation comprising at least one pharmaceutically acceptable carrier and at least one CX3CR1 or fractalkine antagonist.
    Type: Application
    Filed: November 22, 2017
    Publication date: April 12, 2018
    Inventors: Alessandro Fatatis, Joseph M. Salvino, Olimpia Meucci, Whitney L. Gladney
  • Compounds useful for inhibiting metastasis from cancer and methods using same
    Patent number: 9856260
    Abstract: The present invention includes compositions that are useful in preventing or treating metastasis in a subject diagnosed with cancer. The present invention also includes methods of preventing or treating metastasis in a subject diagnosed with cancer, wherein the method comprises administering to the subject in need thereof an effective amount of a pharmaceutical formulation comprising at least one pharmaceutically acceptable carrier and at least one CX3CR1 or fractalkine antagonist.
    Type: Grant
    Filed: June 6, 2016
    Date of Patent: January 2, 2018
    Assignees: Drexel University, Alliance Discovery, Inc.
    Inventors: Alessandro Fatatis, Joseph M. Salvino, Olimpia Meucci, Whitney L. Gladney
  • Compounds Useful for Inhibiting Metastasis from Cancer and Methods Using Same
    Publication number: 20160264587
    Abstract: The present invention includes compositions that are useful in preventing or treating metastasis in a subject diagnosed with cancer. The present invention also includes methods of preventing or treating metastasis in a subject diagnosed with cancer, wherein the method comprises administering to the subject in need thereof an effective amount of a pharmaceutical formulation comprising at least one pharmaceutically acceptable carrier and at least one CX3CR1 or fractalkine antagonist.
    Type: Application
    Filed: June 6, 2016
    Publication date: September 15, 2016
    Inventors: Alessandro Fatatis, Joseph M. Salvino, Olimpia Meucci, Whitney L. Gladney
  • Compounds useful for inhibiting metastasis from cancer and methods using same
    Patent number: 9375474
    Abstract: The present invention includes compositions that are useful in preventing or treating metastasis in a subject diagnosed with cancer. The present invention also includes methods of preventing or treating metastasis in a subject diagnosed with cancer, wherein the method comprises administering to the subject in need thereof an effective amount of a pharmaceutical formulation comprising at least one pharmaceutically acceptable carrier and at least one CX3CR1 or fractalkine antagonist.
    Type: Grant
    Filed: February 25, 2013
    Date of Patent: June 28, 2016
    Assignees: Drexel University, Alliance Discovery, Inc.
    Inventors: Alessandro Fatatis, Joseph M. Salvino, Olimpia Meucci, Whitney L. Gladney